{"id":2896,"date":"2024-10-11T06:39:07","date_gmt":"2024-10-11T06:39:07","guid":{"rendered":"https:\/\/vichsec.org\/guidline\/environmental-impact-assessment-eias-for-veterinary-medicinal-products-vmps-phase-ii\/"},"modified":"2024-10-23T13:58:57","modified_gmt":"2024-10-23T13:58:57","slug":"environmental-impact-assessment-eias-for-veterinary-medicinal-products-vmps-phase-ii","status":"publish","type":"guideline","link":"https:\/\/vichsec.org\/es\/guidline\/environmental-impact-assessment-eias-for-veterinary-medicinal-products-vmps-phase-ii\/","title":{"rendered":"Evaluaci\u00f3n del Impacto Ambiental (EIAs) para medicamentos veterinarios (VMPs) &#8211; Fase 2"},"content":{"rendered":"<p>VICH GL38 (Ecotoxicidad Fase 2) Octubre 2004 &#8211; Implementado en octubre de 2005<\/p>\n","protected":false},"menu_order":97,"template":"","meta":[],"guideline_category":[235],"class_list":["post-2896","guideline","type-guideline","status-publish","hentry","guideline_category-pharmaceuticals-pharma-safety-environmental-safety-es"],"_links":{"self":[{"href":"https:\/\/vichsec.org\/es\/wp-json\/wp\/v2\/guideline\/2896","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vichsec.org\/es\/wp-json\/wp\/v2\/guideline"}],"about":[{"href":"https:\/\/vichsec.org\/es\/wp-json\/wp\/v2\/types\/guideline"}],"wp:attachment":[{"href":"https:\/\/vichsec.org\/es\/wp-json\/wp\/v2\/media?parent=2896"}],"wp:term":[{"taxonomy":"guideline_category","embeddable":true,"href":"https:\/\/vichsec.org\/es\/wp-json\/wp\/v2\/guideline_category?post=2896"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}